Back

DREAM-GNN: Dual-route embedding-aware graph neural networks for drug repositioning

Zhao, Y.; Chen, Y.; Du, J.; Sun, Q.; Wang, R.; Chen, C.

2025-07-10 bioinformatics
10.1101/2025.07.07.663530 bioRxiv
Show abstract

Drug repositioning presents a compelling strategy to accelerate therapeutic development by uncovering new indications for existing compounds. However, current computational methods are often limited in their ability to integrate heterogeneous biomedical data and model the intricate, multi-scale relationships underlying drug-disease associations, while large-scale experimental validation remains prohibitively resource-intensive. Here we present DREAM-GNN (Dual-Route Embedding-Aware Model for Graph Neural Networks), a multi-view deep graph learning framework that incorporates biomedical domain knowledge with two complementary graphs capturing both topological structure and feature similarity to enable accurate and biologically meaningful prediction of drug-disease associations. Extensive experiments on benchmark datasets demonstrate that DREAM-GNN significantly outperforms current state-of-the-art methods in recovering artificially removed repositioning candidates. These results establish DREAM-GNN as a robust and generalizable computational framework with broad potential to streamline drug discovery and advance precision medicine.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.